Francisco Nuno Rocha Gonçalves


AuthID: R-000-VVZ

Confirmed Publications: 51



11
TITLE: Second-Line Immunotherapy Treatment Patterns in Non-Small Cell Lung Cancer in Portugal: An I-O Optimise Cohort Study
AUTHORS: Soares, M; Antunes, L; Oliveira Gomes, J; Pauperio, G; Cardia, J; Redondo, P; Borges, M; Chaib, C; Lacoin, L; Grimson, F; Ralphs, E; Munro, R; Daumont, M; Penrod, JR; O'Donnell, JC; Bento, MJ; Goncalves, FR ;
PUBLISHED: 2021, SOURCE: JOURNAL OF THORACIC ONCOLOGY, VOLUME: 16, ISSUE: 3
INDEXED IN: WOS CrossRef
IN MY: ORCID
12
TITLE: Small cell lung cancer treatment and survival in Portugal: A retrospective analysis from the I-O Optimise initiative  Full Text
AUTHORS: Soares, M; Antunes, L; Redondo, P; Borges, M; Grimson, F; Hermans, R; Chaib, C; Lacoin, L; Juarez Garcia, A; Daumont, MJ; Penrod, JR; Bento, MJ; Gonçalves, FR ;
PUBLISHED: 2021, SOURCE: EUROPEAN JOURNAL OF CANCER CARE, VOLUME: 30, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef: 4
IN MY: ORCID
13
TITLE: The addition of neoadjuvant pertuzumab for the treatment of HER2+breast cancer: a cost estimate with real-world data
AUTHORS: Borges, A; Pereira, F; Redondo, P; Antunes, L; Vieira, C; Antunes, P; Bento, MJ; Sousa, S; Lopes, JM; Rocha Goncalves, F ; de Sousa, JA; Pereira, DS; Borges, M;
PUBLISHED: 2021, SOURCE: HEALTH ECONOMICS REVIEW, VOLUME: 11, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 5
IN MY: ORCID
14
TITLE: Treatment and outcomes for early non-small-cell lung cancer: a retrospective analysis of a Portuguese hospital database
AUTHORS: Soares, M; Antunes, L; Redondo, P; Borges, M; Hermans, R; Patel, D; Grimson, F; Munro, R; Chaib, C; Lacoin, L; Daumont, M; Penrod, JR; O'Donnell, JC; Bento, MJ; Gonçalves, FR ;
PUBLISHED: 2021, SOURCE: LUNG CANCER MANAGEMENT, VOLUME: 10, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef: 2
IN MY: ORCID
15
16
TITLE: Pharmacoeconomic Trends, Applications, and Potential Developments
AUTHORS: Francisco Nuno Rocha-Gonçalves ;
PUBLISHED: 2020, SOURCE: Global Journal on Quality and Safety in Healthcare, VOLUME: 3, ISSUE: 2
INDEXED IN: CrossRef
IN MY: ORCID
17
TITLE: Real-world treatment patterns and survival outcomes for advanced non-small cell lung cancer in the pre-immunotherapy era in Portugal: a retrospective analysis from the I-O Optimise initiative  Full Text
AUTHORS: Soares, M; Antunes, L; Redondo, P; Borges, M; Hermans, R; Patel, D; Grimson, F; Munro, R; Chaib, C; Lacoin, L; Daumont, M; Penrod, JR; O'Donnell, JC; Bento, MJ; Goncalves, FR ;
PUBLISHED: 2020, SOURCE: BMC PULMONARY MEDICINE, VOLUME: 20, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 16
IN MY: ORCID
18
19
TITLE: COST-ESTIMATE OF ADDING NEOADJUVANT PERTUZUMAB FOR THE TREATMENT OF HER2+BREAST CANCER IN AN INSTITUTION IN PORTUGAL  Full Text
AUTHORS: Borges, A; Pereira, F; Redondo, P; Antunes, L; Vieira, C; Antunes, P; Bento, MJ; Sousa, S; Lopes, JM; Goncalves, FR ; de Sousa, JA; Pereira, D; Borges, M;
PUBLISHED: 2019, SOURCE: VALUE IN HEALTH, VOLUME: 22
INDEXED IN: WOS CrossRef: 1
IN MY: ORCID
20
TITLE: Holistic view of patients with melanoma of the skin: how can health systems create value and achieve better clinical outcomes?  Full Text
AUTHORS: Redondo, P; Ribeiro, M; Lopes, M; Borges, M; Goncalves, FR ;
PUBLISHED: 2019, SOURCE: ECANCERMEDICALSCIENCE, VOLUME: 13
INDEXED IN: Scopus WOS CrossRef: 5
IN MY: ORCID
Page 2 of 6. Total results: 51.

footer slogan

Useful Links

Get Help

© 2025 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service